Lescol Retard
Lescol Retard is a medicine authorised by Swissmedic under authorisation number 55489. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 August 2000 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.
| Authorisation number | 55489 |
|---|---|
| Name | Lescol Retard |
| Full name | Lescol Retard, Retardtabletten |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | not stated |
| First authorisation | 29 August 2000 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Lescol Retard, Retardtabletten | B | 29 August 2000 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| The Swissmedic export lists no pack sizes for this medicine. | |||||
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Lescol Retard authorised in Switzerland?
Yes. Lescol Retard is authorised by Swissmedic under authorisation number 55489, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Lescol Retard have?
Lescol Retard is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Lescol Retard?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.